KKR Genetic Disorder L.P.

Insider Reports History

Entity
Company
Location
C/O Kohlberg Kravis Roberts & Co. L.P., 9 West 57 Th Street, Suite 4200, New York, NY
Signature
KKR GENETIC DISORDER L.P., By: KKR Genetic Disorder GP LLC, its general partner, By: /s/ Christopher Lee, Name: Christopher Lee, Title: Assistant Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KKR Genetic Disorder L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. 10%+ Owner Common Stock 25.3M $650M $25.75 Sep 13, 2024 Indirect

Insider Reports Filed by KKR Genetic Disorder L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBIO BridgeBio Pharma, Inc. Sep 13, 2024 1 -$149M 4 Sep 17, 2024 10%+ Owner